Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration

Synapse

Volumn 65, Issue 6, 2011, Pages 479-489

  Villégier, Anne Sophie ^a   Belluzzi, James D ^a   Leslie, Frances M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT2A; MAOI; Microdialysis; Nicotine; Parachloroamphetamine; Self administration

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMPHETAMINE; KETANSERIN; NICOTINE; PARACHLOROAMPHETAMINE; RITANSERIN; SEROTONIN; TRANYLCYPROMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TOBACCO USE DISORDER; TRANYLCYPROMINE; UP-REGULATION;

EID: 79953291008     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20864     Document Type: Article

References (47)

1. Auclair A, Blanc G, Glowinski J, Tassin JP. 2004a. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: Comparison with previous data on alpha1b-adrenergic receptors. J Neurochem 91: 318-326.
2. Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP. 2004b. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20: 3073-3084.
3. Balfour DJ, Ridley DL. 2000. The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction? Pharmacol Biochem Behav 66: 79-85.
4. Batman AM, Munzar P, Beardsley PM. 2005. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Psychopharmacology (Berl) 179: 393-401.
5. Baumann MH, Clark RD, Rothman RB. 2008. Locomotor stimulation produced by 3, 4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90: 208-217.
6. Belluzzi JD, Wang R, Leslie FM. 2005. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30: 705-712.
7. Benmansour S, Brunswick DJ. 1994. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine. Brain Res 650: 305-312.
8. Benowitz NL, Porchet H, Jacob PIII. 1990. Pharmacokinetics, metabolism, and pharmaco dynamics of nicotine. In: Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Wonnacott S, Russell MAK, Stolerman IP, eds., Oxford University Press, Oxford 1990: 112-157.
9. Brodkin J, Malyala A, Nash JF. 1993. Effect of acute monoamine depletion on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 45: 647-653.
10. Brunzell DH, Chang JR, Schneider B, Olausson P, Taylor JR, Picciotto MR. 2006. beta2-Subunit-containing nicotinic acetylcholine receptors are involved in nicotine-induced increases in conditioned reinforcement but not progressive ratio responding for food in C57BL/6 mice. Psychopharmacology (Berl) 184: 328-338.
11. Coggins CR, Murrelle EL, Carchman RA, Heidbrederc C. 2009. Light and intermittent cigarette smokers: A review (1989-2009). Psychopharmacology 207: 343-363.
12. Engberg G, Erhardt S, Sharp T, Hajós M. 2000. Nicotine inhibits firing activity of dorsal raphe 5-HT neurones in vivo. Naunyn Schmiedebergs Arch Pharmacol 362: 41-45.
13. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R. 1996a. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379: 733-736.
14. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP. 1996b. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93: 14065-14069.
15. Fowler JS, Logan J, Wang GJ, Volkow ND. 2003. Monoamine oxidase and cigarette smoking. Neurotoxicology 24: 75-82.
16. Fulford AJ, Marsden CA. 2007. An intact dopaminergic system is required for context conditioned release of 5-HT in the nucleus accumbens of postweaning isolation reared rats. Neuroscience 149: 392-400.
17. Grottick AJ, Corrigall WA, Higgins GA. 2001. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology (Berl) 157: 292-298.
18. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L. 2005. Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25: 8593-8600.
19. Harvey DM, Yasar S, Heishman SJ, Panlilio LV, Henningfield JE, Goldberg SR. 2004. Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl) 175: 134-142.
20. Hauptmann N, Shih JC. 2001. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. Life Sci 68: 1231-1241.
21. Lanteri C, Hernández Vallejo SJ, Salomon L, Doucet EL, Godeheu G, Torrens Y, Houades V, Tassin JP. 2009. Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization. J Neurosci 29: 987-997.
22. Levin ED, Slade S, Johnson M, Petro A, Horton K, Williams P, Rezvani AH, Rose JE. 2008. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol 600: 93-97.
23. Li X, Rainnie DG, McCarley RW, Greene RW. 1998. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci 18: 1904-1912.
24. Ma Z, Strecker RE, McKenna JT, Thakkar MM, McCarley RW, Tao R. 2005. Effects on serotonin of (-)nicotine and dimethylphenylpiperazinium in the dorsal raphe and nucleus accumbens of freely behaving rats. Neuroscience 135: 949-958.
25. Manzardo AM, Stein L, Belluzzi JD. 2002. Rats prefer cocaine over nicotine in a two-lever self-administration choice test. Brain Res 924: 10-19.
26. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Léna C, Le Novère N, de Kerchove d'Exaerde A, Huchet M, Damaj MI, Changeux JP. 1999. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398: 805-810.
27. Mihailescu S, Palomero-Rivero M, Meade-Huerta P, Maza-Flores A, Drucker-Colín R. 1998. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur J Pharmacol 360: 31-36.
28. Nowak P, Szczerbak G, Biedka I, Drosik M, Kostrzewa RM, Brus R. 2006. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study. J Physiol Pharmacol 57: 583-597.
29. Olausson P, Akesson P, Petersson A, Engel JA, Söderpalm B. 2001a. Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacology (Berl) 155: 348-361.
30. Olausson P, Akesson P, Engel JA, Söderpalm B. 2001b. Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Eur J Pharmacol 420: 45-54.
31. Olausson P, Engel JA, Söderpalm B. 2002. Involvement of serotonin in nicotine dependence: Processes relevant to positive and negative regulation of drug intake. Pharmacol Biochem Behav 71: 757-771.
32. Olausson P, Jentsch JD, Taylor JR. 2004a. Nicotine enhances responding with conditioned reinforcement. Psychopharmacology (Berl) 171: 173-178.
33. Olausson P, Jentsch JD, Taylor JR. 2004b. Repeated nicotine exposure enhances responding with conditioned reinforcement. Psychopharmacology (Berl) 173: 98-104.
34. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic.
35. Report USGs. 1989. Reducing the health consequences of smoking. Center for chronic disease prevention and health promotion. Office on Smoking and Health. Surgeon General's Report on Smoking and Health. Chapter 2, p 79-92.
36. Ruiu S, Marchese G, Saba PL, Gessa GL, Pani L. 2000. The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex. Mol Psychiatry 5: 673-677.
37. Sharp T, Zetterstrom T, Christmanson L, Ungerstedt U. 1986. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci Lett 72: 320-324.
38. Shoaib M, Schindler CW, Goldberg SR. 1997. Nicotine self-administration in rats: Strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) 129: 35-43.
39. Summers KL, Giacobini E. 1995. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 20: 753-759.
40. Summers KL, Lippiello P, Giacobini E. 1996. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines. Neurochem Res 21: 1181-1186.
41. Szucs RP, Frankel PS, McMahon LR, Cunningham KA. 2005. Relationship of cocaine-induced c-Fos expression to behaviors and the role of serotonin 5-HT2A receptors in cocaine-induced c-Fos expression. Behav Neurosci 119: 1173-1183.
42. Tassin JP. 2008. Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. Biochem Pharmacol 75: 85-97.
43. Villégier AS, Blanc G, Glowinski J, Tassin JP. 2003. Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav 76: 267-274.
44. Villégier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, Leslie FM, Tassin JP. 2006. Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31: 1704-1713.
45. Villégier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM. 2007. Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52: 1415-1425.
46. Weitemier AZ, Murphy NP. 2009. Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning correlative relationships with preference and aversion. Eur J Neurosci 29: 1015-1026.
47. Zaniewska M, McCreary AC, Przegalinski E, Filip M. 2007. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 571: 156-165.